Literature DB >> 21217059

Effects of low-level α-myosin heavy chain expression on contractile kinetics in porcine myocardium.

Matthew R Locher1, Maria V Razumova, Julian E Stelzer, Holly S Norman, Richard L Moss.   

Abstract

Myosin heavy chain (MHC) isoforms are principal determinants of work capacity in mammalian ventricular myocardium. The ventricles of large mammals including humans normally express ∼10% α-MHC on a predominantly β-MHC background, while in failing human ventricles α-MHC is virtually eliminated, suggesting that low-level α-MHC expression in normal myocardium can accelerate the kinetics of contraction and augment systolic function. To test this hypothesis in a model similar to human myocardium we determined composite rate constants of cross-bridge attachment (f(app)) and detachment (g(app)) in porcine myocardium expressing either 100% α-MHC or 100% β-MHC in order to predict the MHC isoform-specific effect on twitch kinetics. Right atrial (∼100% α-MHC) and left ventricular (∼100% β-MHC) tissue was used to measure myosin ATPase activity, isometric force, and the rate constant of force redevelopment (k(tr)) in solutions of varying Ca(2+) concentration. The rate of ATP utilization and k(tr) were approximately ninefold higher in atrial compared with ventricular myocardium, while tension cost was approximately eightfold greater in atrial myocardium. From these values, we calculated f(app) to be ∼10-fold higher in α- compared with β-MHC, while g(app) was 8-fold higher in α-MHC. Mathematical modeling of an isometric twitch using these rate constants predicts that the expression of 10% α-MHC increases the maximal rate of rise of force (dF/dt(max)) by 92% compared with 0% α-MHC. These results suggest that low-level expression of α-MHC significantly accelerates myocardial twitch kinetics, thereby enhancing systolic function in large mammalian myocardium.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21217059      PMCID: PMC3064314          DOI: 10.1152/ajpheart.00452.2010

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  51 in total

1.  Myosin heavy chain isoform expression in the failing and nonfailing human heart.

Authors:  S Miyata; W Minobe; M R Bristow; L A Leinwand
Journal:  Circ Res       Date:  2000-03-03       Impact factor: 17.367

Review 2.  Structural mechanism of muscle contraction.

Authors:  M A Geeves; K C Holmes
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

3.  MRI myocardial motion and fiber tracking: a confirmation of knowledge from different imaging modalities.

Authors:  Gerald D Buckberg; Aman Mahajan; Bernd Jung; Michael Markl; Juergen Hennig; Manel Ballester-Rodes
Journal:  Eur J Cardiothorac Surg       Date:  2006-03-29       Impact factor: 4.191

Review 4.  Left ventricular structure and function: basic science for cardiac imaging.

Authors:  Partho P Sengupta; Josef Korinek; Marek Belohlavek; Jagat Narula; Mani A Vannan; Arshad Jahangir; Bijoy K Khandheria
Journal:  J Am Coll Cardiol       Date:  2006-10-31       Impact factor: 24.094

5.  Ca2+-independent positive molecular inotropy for failing rabbit and human cardiac muscle by alpha-myosin motor gene transfer.

Authors:  Todd J Herron; Eric Devaney; Lakshmi Mundada; Erik Arden; Sharlene Day; Guadalupe Guerrero-Serna; Immanuel Turner; Margaret Westfall; Joseph M Metzger
Journal:  FASEB J       Date:  2009-10-02       Impact factor: 5.191

6.  Beta-myosin heavy chain myocytes are more resistant to changes in power output induced by ischemic conditions.

Authors:  Aaron C Hinken; Kerry S McDonald
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-19       Impact factor: 4.733

7.  Expression of atrial myosin light chains but not alpha-myosin heavy chains is correlated in vivo with increased ventricular function in patients with hypertrophic obstructive cardiomyopathy.

Authors:  O Ritter; H P Luther; H Haase; L G Baltas; G Baumann; H D Schulte; I Morano
Journal:  J Mol Med (Berl)       Date:  1999-09       Impact factor: 4.599

8.  Role of myosin heavy chain composition in the stretch activation response of rat myocardium.

Authors:  Julian E Stelzer; Stacey L Brickson; Matthew R Locher; Richard L Moss
Journal:  J Physiol       Date:  2006-11-30       Impact factor: 5.182

9.  Transmural variation in myosin heavy chain isoform expression modulates the timing of myocardial force generation in porcine left ventricle.

Authors:  Julian E Stelzer; Holly S Norman; Peter P Chen; Jitandrakumar R Patel; Richard L Moss
Journal:  J Physiol       Date:  2008-09-11       Impact factor: 5.182

10.  Determination of rate constants for turnover of myosin isoforms in rat myocardium: implications for in vivo contractile kinetics.

Authors:  Matthew R Locher; Maria V Razumova; Julian E Stelzer; Holly S Norman; Jitandrakumar R Patel; Richard L Moss
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-04-24       Impact factor: 4.733

View more
  20 in total

1.  Large Animal Models of Ischemic Cardiomyopathy: Are They Enough to Bridge the Translational Gap?

Authors:  Patricia K Nguyen; Joseph C Wu
Journal:  J Nucl Cardiol       Date:  2015-08       Impact factor: 5.952

Review 2.  Postnatal Cardiac Development and Regenerative Potential in Large Mammals.

Authors:  Nivedhitha Velayutham; Emma J Agnew; Katherine E Yutzey
Journal:  Pediatr Cardiol       Date:  2019-07-25       Impact factor: 1.655

3.  Sphingosine-1-Phosphate Receptor Modulator, FTY720, Improves Diastolic Dysfunction and Partially Reverses Atrial Remodeling in a Tm-E180G Mouse Model Linked to Hypertrophic Cardiomyopathy.

Authors:  David M Ryba; Chad M Warren; Chehade N Karam; Robert T Davis; Shamim A K Chowdhury; Manuel G Alvarez; Maximilian McCann; Chong Wee Liew; David F Wieczorek; Peter Varga; R John Solaro; Beata M Wolska
Journal:  Circ Heart Fail       Date:  2019-11-05       Impact factor: 8.790

4.  Study of the Expression Transition of Cardiac Myosin Using Polarization-Dependent SHG Microscopy.

Authors:  Cai Yuan; Xiaolei Zhao; Zhonghai Wang; Thomas K Borg; Tong Ye; Zain I Khalpey; Raymond B Runyan; Yonghong Shao; Bruce Z Gao
Journal:  Biophys J       Date:  2020-01-03       Impact factor: 4.033

5.  Cardiomyopathy mutations in the tail of β-cardiac myosin modify the coiled-coil structure and affect integration into thick filaments in muscle sarcomeres in adult cardiomyocytes.

Authors:  Marcin Wolny; Melanie Colegrave; Lucy Colman; Ed White; Peter J Knight; Michelle Peckham
Journal:  J Biol Chem       Date:  2013-09-18       Impact factor: 5.157

6.  N-terminal extension in cardiac myosin-binding protein C regulates myofilament binding.

Authors:  Thomas A Bunch; Victoria C Lepak; Rhye-Samuel Kanassatega; Brett A Colson
Journal:  J Mol Cell Cardiol       Date:  2018-10-22       Impact factor: 5.000

7.  Transgenic overexpression of ribonucleotide reductase improves cardiac performance.

Authors:  Sarah G Nowakowski; Stephen C Kolwicz; Frederick Steven Korte; Zhaoxiong Luo; Jacqueline N Robinson-Hamm; Jennifer L Page; Frank Brozovich; Robert S Weiss; Rong Tian; Charles E Murry; Michael Regnier
Journal:  Proc Natl Acad Sci U S A       Date:  2013-03-25       Impact factor: 11.205

8.  Regulatory light chain mutants linked to heart disease modify the cardiac myosin lever arm.

Authors:  Thomas P Burghardt; Laura A Sikkink
Journal:  Biochemistry       Date:  2013-02-06       Impact factor: 3.162

9.  Cardiac myosin isoforms exhibit differential rates of MgADP release and MgATP binding detected by myocardial viscoelasticity.

Authors:  Yuan Wang; Bertrand C W Tanner; Andrew T Lombardo; Sarah M Tremble; David W Maughan; Peter Vanburen; Martin M Lewinter; Jeffrey Robbins; Bradley M Palmer
Journal:  J Mol Cell Cardiol       Date:  2012-10-30       Impact factor: 5.000

10.  Comprehensive assessment of chamber-specific and transmural heterogeneity in myofilament protein phosphorylation by top-down mass spectrometry.

Authors:  Zachery R Gregorich; Ying Peng; Nicole M Lane; Jeremy J Wolff; Sijian Wang; Wei Guo; Huseyin Guner; Justin Doop; Timothy A Hacker; Ying Ge
Journal:  J Mol Cell Cardiol       Date:  2015-08-09       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.